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Biomedical and Surgical Sciences, University of Verona, Verona, Italy
Fracture risk reduction by bisphosphonates is only partially explained by BMD. However skeletal structur-
al and biomechanical characteristics play an important role in bone strength, but the effects of bisphos-
phonates on them has not been studied in detail. The aim of our study is to asses the effects of alen-
dronate on the geometrical and biomechanical parameters of femur neck. We evaluated the impact of al-
endronate on periosteal diameter (PD), endosteal diameter (ED), cortical thickness (CT), cross sectional
area (CSA), bending resistance (BBRI) and buckling ratio (BR). These parameters were studied in two
clinical conditions affecting cortical bone, postmenopausal osteoporosis (PO) and primary hyperparathy-
roidism (PHPT). We carried out a longitudinal case-control study on three groups: 30 women with OP
treated with alendronate 70 mg/w (OP/AL), 30 women with mild PHPT treated alendronate 70 mg/w (PH-
PT/AL). 30 osteoporotic women without treatment (PO) served as control group. Baseline and 12 month
DXA hip scans (Lunar Expert) were reanalyzed to obtain femoral geometry and biomechanical parame-
ters. All the groups were comparable for age, age of menopause and femur neck BMD. PHPT group had
a baseline greater ED and DP than those in both osteoporotic group but not a significant greater CT. Con-
sequently BBRI in PHPT group was significantly greater. There were not significant differences between
OP and OP/AL in the baseline geometrical and biomechanical parameters. Hip BMD showed a compara-
ble significant increase after 12 months of alendronate in OP/AL and in PHPT/AL versus their baseline
values and versus 12 months hip BMD in OP group. After one year of follow up DP and ED increased in
all three groups in different manner, so CT decreased in OP but thickened both in PHPT and in OP/AL.
CT thickening was due to a reduced endosteal enlargment in OP/AL while it depended on both a reduced
endosteal erosion and an increased periosteal apposition in PHPT/AL. BBRI improved in both group
treated versus baseline value and versus OP, while BR improved only in PHPT/AL. Our data show that
alendronate improves biomechanical parameters of femur neck through a displacement of cortical bone
mass and suggest that alendronate may not improve cortical strength in a standard manner but endoge-
nous or drug-induced hormonal environment may modulate its effect.
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